Mechanisms of Chromosomal Translocation Breakpoints.- Hematologic Malignancies Following Organ Transplantation.- Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders.- olecular Characterization of the Translocation (10;11)(pl3;ql4): MLL and CALM are Fused to AF10 in Morphologically Different Subsets of Acute Leukemia.- LL-Duplcations are Rare and Associated with Poor Prognosis in Acute Myeloid Leukemia.- Real-Time RT-PCR for the Detection and Quantification of AML1/MTG8 Fusion Transcripts in Patients with t(8;21) Positive AML.- Combined Cytogenetic, FISH and RT-PCR Technique in Detection of t(15; 17) and Monitoring of Minimal Residual Disease in Acute Promyelocytic Leukemia.- RT-PCR in Diagnostics and Monitoring of Acute Myeloid.- Chromosome Aberrations in Primary and Secondary Acute Myeloblastic Leukemia.- Are there Two Main Categories of de Novo Acute Myeloid Leukemias with a Normal Karyotype?.- Asynchronous Expression of AC133 on CD34-Negative Leukemic Blast Cells in Childhood B-Cell Precursor ALL.- Expression of AC133 in Childhood Acute Leukemia.- CD10 Expression in T-Lineage Adult Acute Lymphoblastic Leukemia.- Acute Lymphoblastic Leukemia in Childhood with an Unusual Immunophenotype(CD7+/CD56+/CD33+).- Expression of IGFBP-rP2/CTGF is Specific for Malignant Lymphoblasts of Children with Acute Lymphoblastic Leucemia (ALL).- NM23-H1 Protein Expression as a New Prognostic Factor in Acute Lymphoblastic Leukemia.- Monitoring of Wilms' Tumor Gene Transcription in Leukemia Patients.- Effect of Mutationally Activated Ras on the Ras to MAP Kinase Signaling Pathway and Growth Inhibition of Myeloid Leukemia Cells by Inhibitors of the MAP Kinase Cascade.- C-Jun is a JNK-Independent Coactivator of the PU.1 Transcription Factor.- CD7+ and CD56+ Acute Myelogeneous Leukemia is a Distinct Biologic and Clinical Disease Entity.- The Role of Apoptosis in the Course of Acute Leukemia in Children.- Evaluation of Spontaneous and Therapeutically Induced Apoptosis in Childhood Leukemias.- Involvement of BCL-2 and Bax in the IL-7-Induced Inhibition of Spontaneous Apoptosis in Childhood T-ALL.- Analysis of the Apoptotic Signal Transduction Cascade and New Differentially Expressed Genes in Drug Resistant and Sensitive Hematopoetic Cell Lines.- Transforming Activity of Flt3 in 32D Cells.- Evidence of Angiogenesis in Acute Myeloid Leukemia.- Significance of AC133 and CD34 Expression on Acute Myeloid Leukemia Cells.- Heterogeneity in the Stem Cell Compartment of Newly Diagnosed.- Acute Myeloid Leukemia Analyzed by 4-Colour Immunofluorescence Validation of the IPSS and Other Scoring Systems in Patients with Primary MDS.- Although Patients with AML and Complex Aberrant Karyotype Can be Subdivided Into Different Subtypes by Cytogenetics, Prognosis is Equally Poor.- Pharmacokinetics of Idarubicin: Intracellular Events and Extracellular Concentrations.- Oral Idarubicin in Maintenance Therapy of Acute Myeloid Leukemia.- Phase I Study of Liposomal Daunorubicin (DaunoXome) in Relapsed and Refractory Acute Myeloid Leukemia.- Multi Centre Study of a Combination of Fludarabine Phosphate, Cytosine Arabinoside and Granulocyte Colony Stimulating Factor (FLAG) in Relapsed and Refractory Acute Myeloid Leukaemia and in De Novo RAEB-t.- Modulation of AraC by Fludarabine: Results of Salvage Therapy by AMLCG.- Colony Stimulating Factors in Myelodysplastic Syndromes.- Modulation of Ara-C Toxification by Fludarabine and Hydroxyurea in Leukemia Blasts.- Drug Monitoring of Doxorubicin in Children.- Pharmacokinetics of Daunorubicin Entrapped in Liposomes or Erythrocytes - Phase II Study in Refractory Acute Leukemias.- Drug Monitoring During Maintenance Therapy in Children with ALL.- Modulation of Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia; Preliminary Results.- In-Vitro Cellular Drug Resistance in Acute Non-Lymphoblastic.- Leukemia: Comparisons Between Adults and Children Progn...